BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

210 related articles for article (PubMed ID: 36358789)

  • 1. A Clinical Outcome of the Anti-PD-1 Therapy of Melanoma in Polish Patients Is Mediated by Population-Specific Gut Microbiome Composition.
    Pietrzak B; Tomela K; Olejnik-Schmidt A; Galus Ł; Mackiewicz J; Kaczmarek M; Mackiewicz A; Schmidt M
    Cancers (Basel); 2022 Oct; 14(21):. PubMed ID: 36358789
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Diet, obesity, and the gut microbiome as determinants modulating metabolic outcomes in a non-human primate model.
    Newman TM; Shively CA; Register TC; Appt SE; Yadav H; Colwell RR; Fanelli B; Dadlani M; Graubics K; Nguyen UT; Ramamoorthy S; Uberseder B; Clear KYJ; Wilson AS; Reeves KD; Chappell MC; Tooze JA; Cook KL
    Microbiome; 2021 May; 9(1):100. PubMed ID: 33952353
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Metagenomic Shotgun Sequencing and Unbiased Metabolomic Profiling Identify Specific Human Gut Microbiota and Metabolites Associated with Immune Checkpoint Therapy Efficacy in Melanoma Patients.
    Frankel AE; Coughlin LA; Kim J; Froehlich TW; Xie Y; Frenkel EP; Koh AY
    Neoplasia; 2017 Oct; 19(10):848-855. PubMed ID: 28923537
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The Diversity of Gut Microbiome is Associated With Favorable Responses to Anti-Programmed Death 1 Immunotherapy in Chinese Patients With NSCLC.
    Jin Y; Dong H; Xia L; Yang Y; Zhu Y; Shen Y; Zheng H; Yao C; Wang Y; Lu S
    J Thorac Oncol; 2019 Aug; 14(8):1378-1389. PubMed ID: 31026576
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Fluctuations in Gut Microbiome Composition During Immune Checkpoint Inhibitor Therapy.
    Sarkar J; Cortes Gomez E; Oba T; Chen H; Dy GK; Segal BH; Ernstoff MS; Ito F
    World J Oncol; 2023 Jun; 14(3):178-187. PubMed ID: 37350807
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Checkpoint inhibitor responses can be regulated by the gut microbiota - A systematic review.
    Zeriouh M; Raskov H; Kvich L; Gögenur I; Bennedsen ALB
    Neoplasia; 2023 Sep; 43():100923. PubMed ID: 37603952
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The gut microbiota modulates responses to anti-PD-1 and chemotherapy combination therapy and related adverse events in patients with advanced solid tumors.
    Wu Z; Zhang S; Li L; Huang Z; Huang D; Hu Y
    Front Oncol; 2022; 12():887383. PubMed ID: 36387171
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The Gut Microbiome Is Associated with Clinical Response to Anti-PD-1/PD-L1 Immunotherapy in Gastrointestinal Cancer.
    Peng Z; Cheng S; Kou Y; Wang Z; Jin R; Hu H; Zhang X; Gong JF; Li J; Lu M; Wang X; Zhou J; Lu Z; Zhang Q; Tzeng DTW; Bi D; Tan Y; Shen L
    Cancer Immunol Res; 2020 Oct; 8(10):1251-1261. PubMed ID: 32855157
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Baseline gut microbiota predicts clinical response and colitis in metastatic melanoma patients treated with ipilimumab.
    Chaput N; Lepage P; Coutzac C; Soularue E; Le Roux K; Monot C; Boselli L; Routier E; Cassard L; Collins M; Vaysse T; Marthey L; Eggermont A; Asvatourian V; Lanoy E; Mateus C; Robert C; Carbonnel F
    Ann Oncol; 2017 Jun; 28(6):1368-1379. PubMed ID: 28368458
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Gut microbial species and metabolic pathways associated with response to treatment with immune checkpoint inhibitors in metastatic melanoma.
    Wind TT; Gacesa R; Vich Vila A; de Haan JJ; Jalving M; Weersma RK; Hospers GAP
    Melanoma Res; 2020 Jun; 30(3):235-246. PubMed ID: 31990790
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The Gut Microbiome and Cancer Immunotherapy: Can We Use the Gut Microbiome as a Predictive Biomarker for Clinical Response in Cancer Immunotherapy?
    Oh B; Boyle F; Pavlakis N; Clarke S; Eade T; Hruby G; Lamoury G; Carroll S; Morgia M; Kneebone A; Stevens M; Liu W; Corless B; Molloy M; Kong B; Libermann T; Rosenthal D; Back M
    Cancers (Basel); 2021 Sep; 13(19):. PubMed ID: 34638308
    [No Abstract]   [Full Text] [Related]  

  • 12. Phenylketonuria Diet Promotes Shifts in Firmicutes Populations.
    Bassanini G; Ceccarani C; Borgo F; Severgnini M; Rovelli V; Morace G; Verduci E; Borghi E
    Front Cell Infect Microbiol; 2019; 9():101. PubMed ID: 31058098
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Intestinal microbiota composition of children with infection with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) and multisystem inflammatory syndrome (MIS-C).
    Suskun C; Kilic O; Yilmaz Ciftdogan D; Guven S; Karbuz A; Ozkaya Parlakay A; Kara Y; Kacmaz E; Sahin A; Boga A; Kizmaz Isancli D; Gulhan B; Kanik-Yuksek S; Kiral E; Bozan G; Arslanoglu MO; Kizil MC; Dinleyici M; Us T; Varis A; Kaya M; Vandenplas Y; Dinleyici EC
    Eur J Pediatr; 2022 Aug; 181(8):3175-3191. PubMed ID: 35585256
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Characterization of gut microbiota in patients with primary hepatocellular carcinoma received immune checkpoint inhibitors: A Chinese population-based study.
    Li L; Ye J
    Medicine (Baltimore); 2020 Sep; 99(37):e21788. PubMed ID: 32925716
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Microbial Community of Healthy Thai Vegetarians and Non-Vegetarians, Their Core Gut Microbiota, and Pathogen Risk.
    Ruengsomwong S; La-Ongkham O; Jiang J; Wannissorn B; Nakayama J; Nitisinprasert S
    J Microbiol Biotechnol; 2016 Oct; 26(10):1723-1735. PubMed ID: 27381339
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Gut microbiota and clinical response to immune checkpoint inhibitor therapy in patients with advanced cancer.
    Chang JW; Hsieh JJ; Tsai CY; Chiu HY; Lin YF; Wu CE; Shen YC; Hou MM; Chang CY; Chen JA; Chen CL; Chiu CT; Yeh YM; Chiu CH
    Biomed J; 2024 Jan; ():100698. PubMed ID: 38280521
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Ginseng polysaccharides alter the gut microbiota and kynurenine/tryptophan ratio, potentiating the antitumour effect of antiprogrammed cell death 1/programmed cell death ligand 1 (anti-PD-1/PD-L1) immunotherapy.
    Huang J; Liu D; Wang Y; Liu L; Li J; Yuan J; Jiang Z; Jiang Z; Hsiao WW; Liu H; Khan I; Xie Y; Wu J; Xie Y; Zhang Y; Fu Y; Liao J; Wang W; Lai H; Shi A; Cai J; Luo L; Li R; Yao X; Fan X; Wu Q; Liu Z; Yan P; Lu J; Yang M; Wang L; Cao Y; Wei H; Leung EL
    Gut; 2022 Apr; 71(4):734-745. PubMed ID: 34006584
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Associations between Diet, the Gut Microbiome, and Short-Chain Fatty Acid Production among Older Caribbean Latino Adults.
    Maldonado-Contreras A; Noel SE; Ward DV; Velez M; Mangano KM
    J Acad Nutr Diet; 2020 Dec; 120(12):2047-2060.e6. PubMed ID: 32798072
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Relating Gut Microbiome and Its Modulating Factors to Immunotherapy in Solid Tumors: A Systematic Review.
    Huang C; Li M; Liu B; Zhu H; Dai Q; Fan X; Mehta K; Huang C; Neupane P; Wang F; Sun W; Umar S; Zhong C; Zhang J
    Front Oncol; 2021; 11():642110. PubMed ID: 33816289
    [No Abstract]   [Full Text] [Related]  

  • 20. Early melanoma invasivity correlates with gut fungal and bacterial profiles.
    Vitali F; Colucci R; Di Paola M; Pindo M; De Filippo C; Moretti S; Cavalieri D
    Br J Dermatol; 2022 Jan; 186(1):106-116. PubMed ID: 34227096
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.